Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 10/20 | 0.61 |
| ▸ | VIPR1 | P32241 | 9/20 | 0.59 |
| ▸ | TFPI | P10646 | 1/20 | 0.56 |
| ▸ | BACE1 | P56817 | 1/20 | 0.53 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29694509 | 0.97 | VIPR2 (0.66) | VIPR2VIPR1TFPI | |
| SCHEMBL29694508 | 0.95 | VIPR2 (0.66) | VIPR2VIPR1TFPI | |
| SCHEMBL30176424 | 0.94 | VIPR1 (0.63) | VIPR2VIPR1TFPIPTH1R | |
| SCHEMBL31307250 | 0.92 | VIPR2 (0.57) | VIPR2VIPR1BACE1 | |
| SCHEMBL29461568 | 0.92 | VIPR2 (0.65) | VIPR2VIPR1TFPI | |
| SCHEMBL29453342 | 0.91 | VIPR2 (0.63) | VIPR2VIPR1TFPIBACE1 | |
| SCHEMBL29453340 | 0.91 | VIPR2 (0.63) | VIPR2VIPR1TFPIBACE1 | |
| SCHEMBL29453363 | 0.89 | VIPR2 (0.60) | VIPR2VIPR1TFPIBACE1 | |
| SCHEMBL29453332 | 0.89 | VIPR2 (0.62) | VIPR2VIPR1TFPIBACE1 | |
| SCHEMBL29487597 | 0.88 | VIPR2 (0.63) | VIPR2VIPR1TFPIBACE1PTH1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112745382-B | Bioactive peptide with amino acid structure LTVINQTQKENLR, and preparation method and application thereof | 浙江辉肽生命健康科技有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-112745382-B | Bioactive peptide with amino acid structure LTVINQTQKENLR, and preparation method and application thereof | 浙江辉肽生命健康科技有限公司 | 2022-05-31 | — | — | CN | disclosed |